Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Income Statement [Abstract]    
Sales $ 36,336
Operating expenses:    
General and administrative 1,326,032 1,644,262
Research and development 172,643
Facility operations 531,736 239,325
Depreciation 525,229 354,503
Amortization 367,500
Total operating expenses 2,923,140 2,238,090
Net loss from operations (2,886,804) (2,238,090)
Other income (expense):    
Interest expense (502,372) (81,536)
Amortization of debt discount (2,040,000) (236,364)
Financing costs (109,953)
Change in fair value of derivative liability 1,314,000
Change in fair value of warrant liability 1,915,000
Forgiveness of PPP loan 103,200
Total other income (expense) 686,628 (324,653)
Loss before income taxes (2,200,176) (2,562,743)
Provision for income taxes
Net loss (2,200,176) (2,562,743)
Amoritzation of beneficial conversion feature on Preferred shares (141,500) (817,376)
Accretion on Preferred shares (278,500)
Redemption and exchange of Series D Preferred shares (5,792,947)
Dividends (102,227)
Net loss available for common stockholders $ (2,722,403) $ (9,173,066)
EARNINGS PER SHARE (Basic and diluted) $ (0.00) $ (0.02)
WEIGHTED AVERAGE SHARES OUTSTANDING (Basic and diluted) 665,999,390 501,477,593